Skip to main content
Clinical Trials/NCT00396188
NCT00396188
Completed
Not Applicable

Corneal Analysis - Pathology Detection Aid

Carl Zeiss Meditec, Inc.4 sites in 1 country769 target enrollmentFebruary 2007

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Corneal Diseases
Sponsor
Carl Zeiss Meditec, Inc.
Enrollment
769
Locations
4
Primary Endpoint
Reference values of normal and previously diagnosed corneal conditions by Atlas II corneal topographer
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

The purpose of this study is to determine the ability of a proprietary software screening tool to discriminate normal corneas (front surface of the eye) from previously diagnosed corneal conditions (diseases/surgeries/pathologies) and to determine the repeatabiltity and reproducibility of the Atlas II corneal topographer in normal human corneas.

Detailed Description

1. To establish reference values for SF, CIM, and TKM in subjects with normal corneas. 2. To establish reference values for SF, CIM, and TKM in subjects who underwent myopic laser vision correction. 3. To establish reference values for SF, CIM, and TKM in subjects who underwent hyperopic laser vision correction. 4. To establish reference values for SF, CIM, and TKM in subjects who were diagnosed to have keratoconus. 5. To establish reference values for SF, CIM, and TKM in subjects with history of orthokeratology. 6. To establish reference values for SF, CIM, and TKM in subjects with previously diagnosed corneal conditions (diseases/pathologies/surgeries) affecting the corneal surface that are not listed above. 7. To determine the repeatabiltity and reproducibility of the Atlas II corneal topographer in normal human corneas using true elevation data and axial curvature. 8. To determine the sensitivity, specificity, and accuracy of the Pathfinder II Corneal Analysis software in discriminating normal corneas from previously diagnosed corneal conditions (diseases/pathologies/surgeries) affecting the corneal surface (Phase II).

Registry
clinicaltrials.gov
Start Date
February 2007
End Date
February 2008
Last Updated
10 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients seeking initial laser vision correction that were screened to be good candidates for the procedure.
  • No history of refractive or other ocular surgery.
  • No corneal pathologies.
  • Normal corneal topography.
  • Contact lens wearers should discontinue use at least 2 weeks for hard contacts, and 3 days for soft lenses prior to imaging.
  • Keratoconus
  • An irregular cornea determined by distorted keratometry mires, distortion of the retinoscopic, or ophthalmoscopic red reflex (or a combination of these)
  • At least one of the following biomicroscopic signs: Vogt's striae, Fleischer's ring of \>2 mm arc, or corneal scarring consistent with keratoconus.
  • Contact lens wearers should discontinue use preferably 1 day or at least half an hour prior to imaging.
  • Myopic Laser Vision Correction

Exclusion Criteria

  • Patients that underwent corneal transplantation or any ocular surgery for the following categories: normal, keratoconus, and orthokeratology)
  • Any active infection or inflammation of the cornea.
  • PI decides that subject is not suitable due to medical risk.

Outcomes

Primary Outcomes

Reference values of normal and previously diagnosed corneal conditions by Atlas II corneal topographer

Time Frame: 1-2 hours

Secondary Outcomes

  • Repeatabiltity and reproducibility of the Atlas II corneal topographer in human corneas(1-2 hours)

Study Sites (4)

Loading locations...

Similar Trials